Cite
APA Citation
Ross, S., Thamer, C., Cescutti, J., Meinicke, T., Woerle, H. J., & Broedl, U. C. (n.d.). efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial. Diabetes, obesity & metabolism, 17(7), 699–702. http://access.bl.uk/ark:/81055/vdc_100025935608.0x000032